{"id":1360,"date":"2017-07-20T07:41:31","date_gmt":"2017-07-20T06:41:31","guid":{"rendered":"http:\/\/dose-innova.ccoo.cat\/?p=587"},"modified":"2017-07-20T07:41:31","modified_gmt":"2017-07-20T06:41:31","slug":"reconocimientos","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/reconocimientos\/","title":{"rendered":"Reconeixements"},"content":{"rendered":"<p><span style=\"color: #800000\"><strong><span style=\"font-size: 18pt\">Reconeixements<\/span><\/strong><\/span><\/p>\n<p><span style=\"color: #800000\"><strong><span style=\"font-size: 14pt\">Premis Vinculaci\u00f3<\/span><\/strong><\/span><\/p>\n<p>Es perceben mitjan\u00e7ant la n\u00f2mina en complir-se\u00a025\u00a0o\u00a040\u00a0anys de perman\u00e8ncia en ESTEVE.<\/p>\n<p>L&#8217;import \u00e9s l&#8217;equivalent a\u00a0una mensualitat\u00a0del salari fix brut anual.<\/p>\n<p><span style=\"color: #800000\"><strong><span style=\"font-size: 14pt\">Targeta de Regal d&#8217;El Corte Ingl\u00e9s<\/span><\/strong><\/span><\/p>\n<p>Es lliura en complir-se\u00a020 i 40 anys\u00a0de perman\u00e8ncia en ESTEVE. El valor \u00e9s de 2.500 euros.<\/p>\n<p><strong><span style=\"font-size: 14pt;color: #800000\">2 Dies de Lliure Disposici\u00f3<\/span><\/strong><\/p>\n<p>Les persones amb una antiguitat de\u00a030 o m\u00e9s anys\u00a0en ESTEVE tindran dret a gaudir de\u00a02 dies de lliure disposici\u00f3 anuals, a partir de 2008.    \t    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reconeixements Premis Vinculaci\u00f3 Es perceben mitjan\u00e7ant la n\u00f2mina en complir-se\u00a025\u00a0o\u00a040\u00a0anys de perman\u00e8ncia en ESTEVE. L&#8217;import \u00e9s l&#8217;equivalent a\u00a0una mensualitat\u00a0del salari fix brut anual. Targeta de Regal d&#8217;El Corte Ingl\u00e9s Es &#8230; <a title=\"Reconeixements\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/reconocimientos\/\" aria-label=\"Leer m\u00e1s sobre Reconeixements\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":1098,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-1360","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-beneficissocials_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=1360"}],"version-history":[{"count":0,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1360\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/1098"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=1360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=1360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=1360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}